IGL-200 is a diagnostic test for detecting invasive fungal diseases (IFD), enabling rapid and accurate identification of fungal pathogens in clinical samples. Designed for laboratory use, it supports timely clinical decision-making in immunocompromised patients at high risk of IFD complications.
Manufactured by
Canada
Founded in 1997, Era Biology has been specializing in invasive fungal disease diagnostics for decades. Era Biology has evolved into a group company with 8 wholly owned subsidiaries, including 3 manufacturing entities: Genobio Pharmaceutical Co., Ltd., Beijing Gold Mountainriver Tech Development Co., Ltd., and Huabio Pharmaceutical Co., Ltd.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Associates Of Cape Cod International Inc
United Kingdom · 4 relevant products
Pilot Gene Technology (Hangzhou) Co., Ltd.
China · 2 relevant products
bioactiva diagnostica GmbH
Germany · 5 relevant products
Eurobio-Scientific
United States · 1 relevant product
guangzhou biotron technolongy co.,ltd
China · 1 relevant product
Zhanjiang Bokang Marine Biological Co., Ltd
China · 2 relevant products
POCBio (Nexlab Co., Ltd.)
China · 1 relevant product
Shenzhen Microprofit Biotech Co., Ltd
China · 1 relevant product
Viramed Biotech AG
Germany · 3 relevant products
Dynamiker Biotechnology (Tianjin) Co., Ltd.
China · 7 relevant products
68 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 106 closest product alternatives
Associates Of Cape Cod International Inc · United Kingdom
The only FDA-cleared and CE-marked rapid test for invasive fungal infection (IFI) that detects (1→3)-β-D-glucan in serum. It is considered the gold standard in rapid screening for invasive fungal infections and provides reliable detection for hospital and reference laboratories.
Pilot Gene Technology (Hangzhou) Co., Ltd. · China
Digital PCR-based diagnostic kit for detection and identification of invasive fungal pathogens in blood and tissue samples. Provides rapid results for invasive fungal disease diagnosis.
Associates Of Cape Cod International Inc · United Kingdom
The only FDA-cleared and CE-marked rapid screening test for invasive fungal infection detection that identifies (1→3)-β-D-glucan in serum. Provides rapid diagnosis of life-threatening opportunistic infections in immunocompromised patients.
bioactiva diagnostica GmbH · Germany
INTRAY DM-FUNGID is an interferon-gamma release assay (IGRA) for the detection of latent tuberculosis infection (LTBI) and active TB disease. The assay detects immune responses to Mycobacterium tuberculosis antigens, enabling accurate screening and diagnosis of both latent and active TB infection in clinical and occupational health settings.
Eurobio-Scientific · United States
A diagnostic product for fungal infection detection and identification. This test supports mycological diagnosis in clinical and laboratory settings.
guangzhou biotron technolongy co.,ltd · China
Interferon-gamma release assay for detection of tuberculosis infection and exposure assessment in clinical and occupational health settings.
Zhanjiang Bokang Marine Biological Co., Ltd · China
A diagnostic kit for identifying and quantifying fungal glucans in blood samples, used as a complementary method for clinical pathogen detection. It helps diagnose fungal infections in patients with fever of unknown origin.
POCBio (Nexlab Co., Ltd.) · China
A diagnostic test for detecting gastrointestinal infections. This product supports the diagnosis of GI-related infectious diseases.
Associates Of Cape Cod International Inc · United Kingdom
A rapid diagnostic test for (1→3)-β-D-glucan detection in clinical laboratories supporting early diagnosis of invasive fungal infections. Enables faster treatment decisions for critically ill patients.
Shenzhen Microprofit Biotech Co., Ltd · China
Chromatography-based immunofluorescence test format for qualitative and semi-quantitative pathogen detection. Applicable to infectious disease screening.
Viramed Biotech AG · Germany
Reagents for immunofluorescence testing in infectious disease diagnostics. These reagents enable the detection of antibodies against various infectious pathogens in human serum.
Dynamiker Biotechnology (Tianjin) Co., Ltd. · China
Point-of-care test for rapid detection of invasive fungal diseases, enabling quick identification at the bedside or clinical laboratory. Facilitates early diagnosis and treatment decisions for immunocompromised patients at risk of invasive fungal infections.
94 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products